Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, přehledy
Grantová podpora
MR/N006364/2
Medical Research Council - United Kingdom
MR/V033417/1
Medical Research Council - United Kingdom
PubMed
33606997
DOI
10.1016/s1473-3099(20)30784-2
PII: S1473-3099(20)30784-2
Knihovny.cz E-zdroje
- MeSH
- houby účinky léků genetika izolace a purifikace fyziologie MeSH
- lidé MeSH
- management nemoci MeSH
- mykologie MeSH
- mykózy diagnóza farmakoterapie mikrobiologie MeSH
- směrnice pro lékařskou praxi jako téma MeSH
- společnosti lékařské MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
With increasing numbers of patients needing intensive care or who are immunosuppressed, infections caused by moulds other than Aspergillus spp or Mucorales are increasing. Although antifungal prophylaxis has shown effectiveness in preventing many invasive fungal infections, selective pressure has caused an increase of breakthrough infections caused by Fusarium, Lomentospora, and Scedosporium species, as well as by dematiaceous moulds, Rasamsonia, Schizophyllum, Scopulariopsis, Paecilomyces, Penicillium, Talaromyces and Purpureocillium species. Guidance on the complex multidisciplinary management of infections caused by these pathogens has the potential to improve prognosis. Management routes depend on the availability of diagnostic and therapeutic options. The present recommendations are part of the One World-One Guideline initiative to incorporate regional differences in the epidemiology and management of rare mould infections. Experts from 24 countries contributed their knowledge and analysed published evidence on the diagnosis and treatment of rare mould infections. This consensus document intends to provide practical guidance in clinical decision making by engaging physicians and scientists involved in various aspects of clinical management. Moreover, we identify areas of uncertainty and constraints in optimising this management.
Department of Clinical Microbiology Trinity College Dublin St James's Hospital Campus Dublin Ireland
Department of Internal Medicine Federal University of Rio de Janeiro Rio de Janeiro Brazil
Department of Laboratory Medicne and Pathology Hamad Medical Corporation Doha Qatar
Department of Medical Mycology Vallabhbhai Patel Chest Institute University of Delhi Delhi India
Department of Microbiology University of Colombo Colombo Sri Lanka
Department of Microbiology University of Hong Kong Hong Kong China
Department of Public Health Clinics Hospital Federal University of Parana Curitiba Brazil
Division of Infectious Diseases University of Toronto Toronto ON Canada
Division of Infectious Diseases Wayne State University Detroit MI USA
Medical Research Council Centre for Medical Mycology University of Exeter Exeter UK
Section of Infectious Diseases and Tropical Medicine Medical University of Graz Graz Austria
Sheba Medical Center and Sackler School of Medicine Tel Aviv University Tel Aviv Israel
University Hospital Puerta de Hierro Majadahonda Madrid Spain
University of Minnesota Minneapolis MN USA
UT Health San Antonio and South Texas Veterans Health Care System San Antonio TX USA
Citace poskytuje Crossref.org